BIMODALITY AND TRIMODALITY THERAPY IN STAGE III NSCLC: ANALYSIS OF TOXICITY AND PATTERNS OF RECURRENCE

被引：0
|
作者：
Van Reij, Ellen J. F.
Phernambucq, Erik C.
De Haan, Patricia F.
Oei, Swie S.
Smit, Egbert F. [1 ]
Paul, M. A. [2 ]
Senan, Suresh
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; trimodality; advanged stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1590 / S1590
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF THE RADIOTHERAPEUTIC EFFICACY IN NSCLC WITH POSTOPERATIVE MEDIASTINAL LYMPH NODES RECURRENCE AND STAGE III
    Imai, Hisao
    Murakami, Haruyasu
    Yoshino, Reiko
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Tomizawa, Yoshio
    Takahashi, Toshiaki
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [42] Risk Factors Associated with Recurrence Following Curative Therapy for Stage I NSCLC
    Butts, E.
    Gococo-Benore, D.
    Pai, T.
    Moustafa, M. Alhaj
    Heng, F.
    Chen, R.
    Manochakian, R.
    Lou, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S283 - S283
  • [43] Lymphocyte Sparing Radiation Therapy for stage III NSCLC: a dosimetric study
    Fernandes, P.
    Jourani, Y.
    Birkfellner, W.
    Charlier, F.
    Ferreira, A.
    de Ven, G. Van
    Moretti, L.
    Fardeau, E.
    Van Gestel, D.
    Reynaert, N.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S498 - S500
  • [44] Clinical and research priorities for combined modality therapy in stage III NSCLC
    Lin, Angela
    Bezjak, Andrea
    [J]. LUNG CANCER MANAGEMENT, 2016, 5 (01) : 43 - 50
  • [45] Optimal Therapy of Stage III NSCLC: The Role of Surgery in the Era of Immunotherapy
    Moore, S.
    Ho, C.
    Leung, B.
    Wu, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S861 - S861
  • [46] Outcomes and Treatment Patterns for Recurrence following Concurrent Chemoradiation and Consolidation Immunotherapy in Unresectable Stage III NSCLC: A Multi-Center Study
    Young, Philip
    Sharp, John
    Michaels, Kenan
    Fultineer, Kylie
    Hall, Richard
    Lynch, Alia
    Thomas, Marie
    Owen, Dwight
    Gentzler, Ryan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E58 - E59
  • [47] Patterns of Recurrence and Its Value to Target of Postoperative Radiation Therapy in Patients of Stage III Thoracic Esophageal Carcinoma
    Wang, Y. X.
    Yang, Q.
    Li, J.
    He, M.
    Yao, J.
    Qi, Z.
    Qiao, X. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E135 - E135
  • [48] Evaluation of outcome and toxicity of Durvalumab treatment after CRT in inoperable stage III NSCLC
    Kaesmann, L.
    Taugner, J.
    Eze, C.
    Roengvoraphoj, O.
    Belka, C.
    Manapov, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S532 - S532
  • [49] Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer confined to the pelvis
    Patel, S
    Gilbert, L
    Portelance, L
    Stanimir, G
    Souhami, L
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S64 - S65
  • [50] Radical hypofractionated VMAT-RA for stage III NSCLC in the elderly: feasibility and toxicity
    Ascolese, A. M.
    Franceschini, D.
    De Rose, F.
    Cozzi, L.
    Navarria, P.
    Tozzi, A.
    Iftode, C.
    Villa, E.
    Franzese, C.
    Comito, T.
    D'agostino, G.
    Tomatis, S.
    Liardo, L.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S670 - S670
12345